235 related articles for article (PubMed ID: 18056459)
1. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C
Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
4. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors.
Ellis DJ; Lawman ZK; Bonham K
Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.
Kumar KS; Sonnemann J; Beck JF
Oncol Rep; 2006 Nov; 16(5):1047-52. PubMed ID: 17016591
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.
Sonnemann J; Hüls I; Sigler M; Palani CD; Hong le TT; Völker U; Kroemer HK; Beck JF
Oncol Rep; 2008 Jul; 20(1):219-24. PubMed ID: 18575740
[TBL] [Abstract][Full Text] [Related]
8. Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells.
Rao J; Bhattacharya D; Banerjee B; Sarin A; Shivashankar GV
Biochem Biophys Res Commun; 2007 Nov; 363(2):263-8. PubMed ID: 17869223
[TBL] [Abstract][Full Text] [Related]
9. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
10. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments.
Karagiannis TC; Harikrishnan KN; El-Osta A
Oncogene; 2007 Jun; 26(27):3963-71. PubMed ID: 17213813
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
[TBL] [Abstract][Full Text] [Related]
12. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation.
Rho JH; Kang DY; Park KJ; Choi HJ; Lee HS; Yee SB; Yoo YH
Int J Oncol; 2005 Aug; 27(2):465-71. PubMed ID: 16010429
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
Kouraklis G; Theocharis S
Oncol Rep; 2006 Feb; 15(2):489-94. PubMed ID: 16391874
[TBL] [Abstract][Full Text] [Related]
16. No need to be HAMLET or BAMLET to interact with histones: binding of monomeric alpha-lactalbumin to histones and basic poly-amino acids.
Permyakov SE; Pershikova IV; Khokhlova TI; Uversky VN; Permyakov EA
Biochemistry; 2004 May; 43(19):5575-82. PubMed ID: 15134431
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors as anti-neoplastic agents.
Batty N; Malouf GG; Issa JP
Cancer Lett; 2009 Aug; 280(2):192-200. PubMed ID: 19345475
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin.
Tóth KF; Knoch TA; Wachsmuth M; Frank-Stöhr M; Stöhr M; Bacher CP; Müller G; Rippe K
J Cell Sci; 2004 Aug; 117(Pt 18):4277-87. PubMed ID: 15292402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]